AGP Picks
View all

Golden State Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Golden State Newswire.

Press releases published on May 4, 2026

GEMI Investors Have Opportunity to Lead Gemini Space Station, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Round Table Pizza Fires Up New Nashville Hot Menu
CWH Investors Have Opportunity to Lead Camping World Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Talkdesk announces new integration to deliver unified healthcare experience and outcomes analytics
Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026
Summit Therapeutics Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Spok Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Operant AI Launches Endpoint Protector: Securing Shadow AI, Coding Agents, and MCP Across the Enterprise
ASUS Releases 2026 Future of Small Business Report
CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition
Turtle Beach Corporation Restructures Credit Facilities to Enhance Capital Return Flexibility
EOSE Investors Have Opportunity to Lead Eos Energy Enterprises, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Fluence Energy, Inc. (FLNC), Fly-E Group, Inc. (FLYE), Fortrea Holdings, Inc. (FTRE), and Freeport-McMoRan Inc. (FCX)
DRVN Investors Have Opportunity to Lead Driven Brands Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm
Barfresh to Present at the LD Micro Invitational XVI
NeoVolta Announces Timing of Third Quarter Fiscal 2026 Earnings Release and Conference Call
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Golden State Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.